Genz 99067
Alternative Names: Genz-99067Latest Information Update: 31 Mar 2022
At a glance
- Originator Genzyme Corporation
- Developer Sanofi
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Metabolic disorders
Most Recent Events
- 26 Dec 2016 Discontinued - Preclinical for Metabolic disorders in USA (unspecified route)
- 04 May 2006 No development reported - Preclinical for Metabolic disorders in USA (unspecified route)
- 29 Jul 2003 Genzyme General, Genzyme Biosurgery and Genzyme Molecular Oncology are now called Genzyme Corporation